181 related articles for article (PubMed ID: 20055587)
1. Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.
Riva C; Lai A; Caramma I; Corvasce S; Violin M; Dehò L; Prati F; Rossi C; Colombo MC; Capetti A; Franzetti M; Rossini V; Tambussi G; Ciccozzi M; Suligoi B; Mussini C; Rezza G; Balotta C
AIDS Res Hum Retroviruses; 2010 Jan; 26(1):41-9. PubMed ID: 20055587
[TBL] [Abstract][Full Text] [Related]
2. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
[TBL] [Abstract][Full Text] [Related]
3. Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients.
Machado LY; Dubed M; Díaz H; Ruiz N; Romay D; Váldes N; Blanco M; Silva E
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):411-4. PubMed ID: 22985307
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
[TBL] [Abstract][Full Text] [Related]
5. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.
Fabeni L; Alteri C; Di Carlo D; Orchi N; Carioti L; Bertoli A; Gori C; Forbici F; Continenza F; Maffongelli G; Pinnetti C; Vergori A; Mondi A; Ammassari A; Borghi V; Giuliani M; De Carli G; Pittalis S; Grisetti S; Pennica A; Mastroianni CM; Montella F; Cristaudo A; Mussini C; Girardi E; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM; ;
J Antimicrob Chemother; 2017 Oct; 72(10):2837-2845. PubMed ID: 29091206
[TBL] [Abstract][Full Text] [Related]
6. Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
Alexiev I; Shankar A; Wensing AM; Beshkov D; Elenkov I; Stoycheva M; Nikolova D; Nikolova M; Switzer WM
J Antimicrob Chemother; 2015; 70(6):1874-80. PubMed ID: 25652746
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.
Grgic I; Lepej SZ; Lunar MM; Poljak M; Vince A; Vrakela IB; Planinic A; Seme K; Begovac J
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):329-36. PubMed ID: 22906365
[TBL] [Abstract][Full Text] [Related]
9. Incident and long-term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.
Lima YA; Cardoso LP; Reis MN; Stefani MM
J Med Virol; 2016 Nov; 88(11):1936-43. PubMed ID: 27037910
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
11. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.
Paraskevis D; Magiorkinis E; Katsoulidou A; Hatzitheodorou E; Antoniadou A; Papadopoulos A; Poulakou G; Paparizos V; Botsi C; Stavrianeas N; Lelekis M; Chini M; Gargalianos P; Magafas N; Lazanas M; Chryssos G; Petrikkos G; Panos G; Kordossis T; Theodoridou M; Sypsa V; Hatzakis A;
Virus Res; 2005 Sep; 112(1-2):115-22. PubMed ID: 16022906
[TBL] [Abstract][Full Text] [Related]
13. Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda.
Reynolds SJ; Ssempijja V; Galiwango R; Ndyanabo A; Nakigozi G; Lyagoba F; Nazziwa J; Redd A; Lamers SL; Gray R; Wawer M; Serwadda D; Quinn TC
AIDS Res Hum Retroviruses; 2017 May; 33(5):448-451. PubMed ID: 27798967
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
[TBL] [Abstract][Full Text] [Related]
15. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
[TBL] [Abstract][Full Text] [Related]
16. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and circulation patterns of variant, atypical and resistant HIV in Los Angeles County (2007-2009).
Sey K; Ma Y; Lan YC; Song N; Hu YW; Ou Y; Frye D
J Med Virol; 2014 Oct; 86(10):1639-47. PubMed ID: 24976142
[TBL] [Abstract][Full Text] [Related]
18. Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.
De Mendoza C; Garrido C; Poveda E; Corral A; Zahonero N; Treviño A; Anta L; Soriano V
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):967-72. PubMed ID: 19842792
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
[TBL] [Abstract][Full Text] [Related]
20. Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience.
Mazzuti L; Melengu T; Falasca F; Calabretto M; Cella E; Ciccozzi M; Mezzaroma I; Iaiani G; Spaziante M; d'Ettorre G; Fimiani C; Vullo V; Antonelli G; Turriziani O
J Glob Antimicrob Resist; 2020 Mar; 20():298-303. PubMed ID: 31518723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
